Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight
出版年份 2021 全文链接
标题
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight
作者
关键词
-
出版物
JOURNAL OF AFFECTIVE DISORDERS
Volume 289, Issue -, Pages 167-176
出版商
Elsevier BV
发表日期
2021-04-23
DOI
10.1016/j.jad.2021.04.017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Obesity in adults: a clinical practice guideline
- (2020) Sean Wharton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Does obesity and diabetes mellitus metastasize to the brain? “Metaboptosis” and implications for drug discovery and development
- (2019) Roger S. McIntyre et al. CNS SPECTRUMS
- Effort-based decision-making is affected by overweight/obesity in major depressive disorder
- (2019) Rodrigo B. Mansur et al. JOURNAL OF AFFECTIVE DISORDERS
- Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
- (2018) Roger S. McIntyre et al. HARVARD REVIEW OF PSYCHIATRY
- Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways
- (2018) Silvia R. S. Ouakinin et al. Frontiers in Endocrinology
- The long-term effect of bariatric surgery on depression and anxiety
- (2018) Hartej Gill et al. JOURNAL OF AFFECTIVE DISORDERS
- The interface of depression and obesity
- (2017) Nattinee Jantaratnotai et al. Obesity Research & Clinical Practice
- Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
- (2016) Young Woo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity
- (2016) Amy Halseth et al. Obesity
- Is increased antidepressant exposure a contributory factor to the obesity pandemic?
- (2016) S H Lee et al. Translational Psychiatry
- Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care
- (2015) Paula Brauer et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis
- (2011) A N Fabricatore et al. INTERNATIONAL JOURNAL OF OBESITY
- Overweight, Obesity, and Depression
- (2010) Floriana S. Luppino et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started